Search

Yu, Darrick L, Ashley A Stegelmeier, Natalie Chow, Amira D Rghei, Kathy Matuszewska, Jack Lawler, Byram W Bridle, James J Petrik, and Sarah K Wootton. 2020. “AAV-Mediated Expression of 3TSR Inhibits Tumor and Metastatic Lesion Development and Extends Survival in a Murine Model of Epithelial Ovarian Carcinoma.”. Cancer Gene Therapy 27 (5): 356-67.

Kazerounian, Shideh, and Jack Lawler. 2018. “Integration of Pro- and Anti-Angiogenic Signals by Endothelial Cells.”. Journal of Cell Communication and Signaling 12 (1): 171-79.

Lopez-Ramirez, Miguel Alejandro, Gregory Fonseca, Hussein A Zeineddine, Romuald Girard, Thomas Moore, Angela Pham, Ying Cao, et al. 2017. “Thrombospondin1 (TSP1) Replacement Prevents Cerebral Cavernous Malformations.”. The Journal of Experimental Medicine 214 (11): 3331-46.

Lawler, Jack. 2016. “When Is a Thrombogenic Matrix Not Thrombogenic?”. Blood 128 (12): 1543-4.

Sims, Jennifer N, and Jack Lawler. 2015. “Thrombospondin-1-Based Antiangiogenic Therapy.”. Journal of Ocular Pharmacology and Therapeutics : The Official Journal of the Association for Ocular Pharmacology and Therapeutics 31 (7): 366-70.

Lawler, Jack. 2022. “Counter Regulation of Tumor Angiogenesis by Vascular Endothelial Growth Factor and Thrombospondin-1.”. Seminars in Cancer Biology 86 (Pt 2): 126-35.

Tan, Kemin, and Jack Lawler. 2009. “The Interaction of Thrombospondins With Extracellular Matrix Proteins.”. Journal of Cell Communication and Signaling 3 (3-4): 177-87.

Ren, Bin, Keli Song, Sareh Parangi, Taiguang Jin, Min Ye, Robin Humphreys, Mark Duquette, et al. 2009. “A Double Hit to Kill Tumor and Endothelial Cells by TRAIL and Antiangiogenic 3TSR.”. Cancer Research 69 (9): 3856-65.

Yee, Karen O, Caitlin M Connolly, Mark Duquette, Shideh Kazerounian, Raymond Washington, and Jack Lawler. 2009. “The Effect of Thrombospondin-1 on Breast Cancer Metastasis.”. Breast Cancer Research and Treatment 114 (1): 85-96.

Ali, Naeem A, Alice A Gaughan, Charles G Orosz, Chris P Baran, Sara McMaken, Yijie Wang, Timothy D Eubank, et al. 2008. “Latency Associated Peptide Has in Vitro and in Vivo Immune Effects Independent of TGF-Beta1.”. PloS One 3 (4): e1914.